| - GRCh37:
- Chr11:63533279-65429676
| ARL2, ATG2A, BAD, BATF2, CAPN1, CATSPERZ, CCDC88B, CDC42BPG, CDC42EP2, CDCA5, COX8A, DNAJC4, DPF2, EHBP1L1, EHD1, ESRRA, FAM89B, FAU, FERMT3, FKBP2, FLRT1, FRMD8, GPHA2, GPR137, KCNK4, KCNK7, LTBP3, MACROD1, MAJIN, MALAT1, MAP3K11, MAP4K2, MARK2, MEN1, MIR192, MIR194-2, MRPL49, NAA40, NAALADL1, NEAT1, NRXN2, NUDT22, OTUB1, PCNX3, PLCB3, POLA2, PPP1R14B, PPP2R5B, PRDX5, PYGM, RASGRP2, RCOR2, RELA, RPS6KA4, SAC3D1, SCYL1, SF1, SIPA1, SLC22A11, SLC22A12, SLC25A45, SNX15, SPDYC, SPINDOC, STIP1, SYVN1, TIGD3, TM7SF2, TRMT112, TRPT1, VEGFB, VPS51, ZFPL1, ZFTA, ZNHIT2, ZNRD2 | | Ependymoma | Likely pathogenic (May 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr10:43604617
- GRCh38:
- Chr10:43109169
| RET | S401N, S147N, S305N, S358N, S71N, S159N, S255N | Ependymoma | Uncertain significance (Aug 26, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:47637348
- GRCh38:
- Chr2:47410209
| MSH2 | V161A, V95A | Hereditary cancer-predisposing syndrome, Ependymoma, Hereditary nonpolyposis colorectal neoplasms
| Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr15:31360292
- GRCh38:
- Chr15:31068089
| TRPM1 | I73L, I112L, I95L | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr17:70845779
- GRCh38:
- Chr17:72849640
| SLC39A11 | V199F, V206F | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr5:148406172
- GRCh38:
- Chr5:149026609
| SH3TC2 | S1006fs | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr22:36960829
- GRCh38:
- Chr22:36564782
| CACNG2 | Y181H, Y158H | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr8:37691223-37691241
- GRCh38:
- Chr8:37833705-37833723
| ADGRA2 | N439fs | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr6:152674554
- GRCh38:
- Chr6:152353419
| SYNE1 | F3684L, F3699L | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrMT:11032
- GRCh38:
- ChrMT:11032
| MT-ND4 | | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:33038668
- GRCh38:
- Chr3:32997176
| GLB1 | A635P, A605P, A504P, A683P | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr1:119965128
- GRCh38:
- Chr1:119422505
| HSD3B2 | R335Q | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr22:19865626
- GRCh38:
- Chr22:19878103
| TXNRD2 | A478P, A477P, A382P, A448P | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr4:1843382
- GRCh38:
- Chr4:1841655
| LETM1 | V96M | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr14:103336591
- GRCh38:
- Chr14:102870254
| TRAF3 | P18R | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr2:39552678
- GRCh38:
- Chr2:39325537
| MAP4K3 | F300S | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr6:150001239
- GRCh38:
- Chr6:149680103
| LATS1 | D509H, D684H, D789H | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr22:30051617
- GRCh38:
- Chr22:29655628
| NF2 | W184*, W101*, W142*, W143* | Ependymoma | Likely pathogenic (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr1:6662377
- GRCh38:
- Chr1:6602317
| KLHL21 | E167D | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrX:48780465
- GRCh38:
- ChrX:48923188
| OTUD5 | P346T, P563T, P568T | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr11:128840363
- GRCh38:
- Chr11:128970468
| ARHGAP32 | T1219S, T1568S, T1528S, T1582S | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrX:154456711
- GRCh38:
- ChrX:155228429
| VBP1 | L111M, L106M, L147M, L74M | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrX:155003588
- ChrY:59106594
- GRCh38:
- ChrX:155773926
- ChrY:56960446
| SPRY3 | R19C | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr10:5494455
- GRCh38:
- Chr10:5452492
| NET1 | E166D, E112D | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr22:32241141
- GRCh38:
- Chr22:31845155
| DEPDC5 | W902*, W971*, W952*, W980* | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr16:3016650
- GRCh38:
- Chr16:2966649
| KREMEN2 | G165V | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr10:76788409
- GRCh38:
- Chr10:75028651
| KAT6B | P1276L, P495L, P984L, P1093L, P581L, P930L, P921L, P713L | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr22:31741027
- GRCh38:
- Chr22:31345041
| PATZ1 | D188Y | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrX:82764345
- GRCh38:
- ChrX:83509337
| POU3F4 | P338L | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr3:56716938
- GRCh38:
- Chr3:56682910
| TASOR | E33K | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- ChrX:48558731
- GRCh38:
- ChrX:48700340
| SUV39H1 | R139C, R150C | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr16:88052070
- GRCh38:
- Chr16:88018464
| BANP | N192S, N223S, N231S, N198S, N128S, N237S, N89S | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr5:56210766-56210774
- GRCh38:
- Chr5:56914939-56914947
| SETD9 | | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr5:141016298-141016308
- GRCh38:
- Chr5:141636731-141636741
| HDAC3, LOC129994870 | | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr1:155742897
- GRCh38:
- Chr1:155773106
| GON4L | N819D | Ependymoma | Uncertain significance (Dec 29, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr11:64575111
- GRCh38:
- Chr11:64807638-64807639
| MEN1 | K238fs, K233fs, K198fs | Ependymoma | Pathogenic (Dec 29, 2017) | no assertion criteria provided |